Prevention of Infection due to Pneumocystis carinii

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 5, 1998, Pages 995-1004

  Fishman, Jay Alan ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATOVAQUONE; AZITHROMYCIN; CLARITHROMYCIN; CLINDAMYCIN; COTRIMOXAZOLE; DAPSONE; FANSIDAR; MACROLIDE; PENTAMIDINE; PRIMAQUINE; PYRIMETHAMINE; TACROLIMUS;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBIOTIC PROPHYLAXIS; ANTIMICROBIAL THERAPY; BRONCHOSPASM; DRUG INDICATION; DRUG MEGADOSE; DRUG SENSITIVITY; DRUG TOLERABILITY; ELECTROLYTE DISTURBANCE; GASTROINTESTINAL SYMPTOM; HEMATOLOGIC DISEASE; HUMAN; HYPERSENSITIVITY; IMMUNE DEFICIENCY; PNEUMOCYSTIS CARINII; PNEUMOCYSTOSIS; PRIORITY JOURNAL; REVIEW; TREATMENT FAILURE; TREATMENT PLANNING; VACCINE PRODUCTION;

EID: 0031959697     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.5.995     Document Type: Review

References (144)

1. Antinori, A., R. Murri, A. Ammassari, A. De Luca, A. Linzalone, and A. Cingolani. 1995. Aerosolized pentamidine, cotrimoxazole and dapsonepyrimethamine for primary prophylaxis of Pneumocystis carinii pneumonia and Toxoplasma encephalitis. J. Acquired Immune Defic. Syndr. 9:1343-1350.
2. Arend, S. M., R. G. Westendorp, F. P. Kroon, J. W. van't Wout, and J. P. Vandenbroucke. 1996. Rejection treatment and cytomegalovirus infection as risk factors for Pneumocystis carinii pneumonia in renal transplant recipients. Clin. Infect Dis. 22:920-925.
3. Balkovec, J. M., R. M. Black, M. L. Hammond, J. V. Heck, R. A. Zambias, G. Abruzzo, K. Bartizal, H. Kropp, C. Trainor, R. E. Schwartz, and D. M. Schmatz. 1992. Synthesis, stability, and biological evaluation of water-soluble prodrugs of a new echinocandin lipopeptide. J. Med. Chem. 35:194-198.
4. Barber, B. A., P. S. Pegram, and K. P. High. 1996. Clindamycin/primaquine as prophylaxis for Pneumocystis carinii pneumonia. Clin. Infect. Dis. 23: 718-722.
5. Barkholt, L., B. G. Ericzon, J. Tollemar, A. S. Malmborg, A. Ehrnst, and H. Wilczek. 1993. Infections in human liver recipients: different patterns early and late after transplantation. Transplant. Int. 6:77-84.
6. + antibody-immunosuppressed mouse models of Pneumocystis carinii pneumonia for evaluation of drugs and leukocytes. Clin. Diagn. Lab. Immunol. 1:511-516.
7. Bartlett, M. S., S. Queener, M. Shaw, J. Richardson, and J. W. Smith. 1994. Pneumocystis carinii is resistant to imidazole antifungal agents. Antimicrob. Agents Chemother. 38:1859-1861.
8. Bartlett, M. S., M. Shaw, P. Navaran, J. W. Smith, and S. Queener. 1995. Evaluation of potent inhibitors of dihydrofolate reductase in a culture model for growth of Pneumocystis carinii. Antimicrob. Agents Chemother. 39:2436-2441.
9. Bartlett, M. S., J. A. Fishman, M. M. Durkin, S. F. Queener, and J. W. Smith. 1990. Pneumocystis carinii: improved models to study efficacy of drugs for the treatment or prophylaxis of Pneumocystis pneumonia. Exp. Parasitol. 70:100-106.
10. Bartlett, M. S., J. A. Fishman, S. F. Queener, and J. Smith. 1988. New rat model of Pneumocystis carinii infection. J. Clin. Microbiol. 26:1100-1102.
11. 2 enrolled in CPCRA 036, abstr. 329. In Abstracts of the 35th Annual Meeting of the Infectious Disease Society of America 1997.
12. Beck, J. M., M. L. Warnock, J. L. Curtis, M. J. Sniezek, S. M. Arraj-Peffer, H. B. Kaltreider, and J. E. Shellito. 1991. Inflammatory responses to Pneumocystis carinii in mice selectively depleted of helper T lymphocytes. Am. J. Respir. Cell. Mol. Biol. 5:186-197.
13. Beumont, M. G., A. Graziani, P. A. Ubel, and R. R. MacGregor. 1996. Safety of dapsone as Pneumocystis carinii pneumonia prophylaxis in HIV-infected patients with allergies to trimethoprim-sulfamethoxazole. Am. J. Med. 100:611-616.
14. Borleffs, J. C. C. 1992. Pentamidine versus two doses of cotrimoxazole in primary prophylaxis of Pneumocystis carinii pneumonia in HIV-infected patients, abstr. O-8A. In International Congress on Drug Therapy of HIV Infection.
15. Bozzette, S. A., D. M. Finkelstein, S. A. Spector, P. Frame, W. G. Powderly, W. He, L. Phillips, D. Craven, C. Van der Horst, J. Feinberg, and NIAID AIDS Clinical Trials Group. 1995. A randomized trial of three anti-Pneumocystis agents in patients with advanced human immunodeficiency virus infection. N. Engl. J. Med. 332:693-699.
16. Bradburne, P. M., D. B. Bettensohn, S. M. Opal, and F. D. McCool. 1989. Relapse of Pneumocystis carinii pneumonia in the upper lobes during aerosol pentamidine prophylaxis. Thorax 44:591-593.
17. Branten, A. J., P. J. Beckers, and M. Tiggeler. 1995. Pneumocystis carinii pneumonia in renal transplant recipients. Nephrol. Dial. Transplant. 10: 1194-1197.
18. Burack, J. H., J. A. Hahn, D. Saint-Maurice, and M. A. Jacobson. 1994. Microbiology of community acquired bacterial pneumonia in persons with and at risk for human immunodeficiency virus type 1 infection. Arch. Intern. Med. 154:2589-2596.
19. Carl, J. L. 1995. Evaluation of the cost effectiveness of trimethoprim/ sulfamethoazole (TMP/SMX) desensitization in HIV-infected patients with intolerance to TMP/SMX, abstr. I221b, p. 245. In Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
20. Centers for Disease Control and Prevention. 1997. 1997 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. Morbid. Mortal. Weekly Rep. 46:1-46.
21. Chave, J., S. David, J. Wauters, and P. Francioli. 1991. Transmission of Pneumocystis carinii from AIDS patients to other immunosuppressed patients: a cluster of Pneumocystis carinii pneumonia in renal transplant recipients. AIDS 5:927-932.
22. Conte, J. E., Jr., and J. A. Golden. 1995. Intrapulmonary and systemic pharmacokinetics of aerosolized pentamidine used for prophylaxis of Pneumocystis carinii pneumonia in patients infected with human immunodeficiency virus. J. Clin. Pharmacol. 35:1166-1173.
23. Cruciani, M., G. Gatti, C. Mengoli, A. Cazzadori, L. Lazzarini, F. Miletich, M. S. Graziani, M. Malena, and D. Bassetti. 1997. Penetration of dapsone into the pulmonary lining fluid of human immunodeficiency virus type 1-infected patients. Antimicrob. Agents Chemother. 41:1077-1081.
24. Cushion, M. T., D. Stanforth, M. J. Linke, and P. D. Walzer. 1985. Method of testing the susceptibility of Pneumocystis carinii to antimicrobial agents in vitro. Antimicrob. Agents Chemother. 28:796-801.
25. Duval, X., P. Clayette, N. Bosquet, P. Frettier, M. Martin, D. Salmon-Ceron, J. Vilde, and D. Dormont. 1996. Effect of dapsone (DDS) on HIV-1 replication in primary cell culture, abstr. A10, p. 188 In Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
26. Edman, J. C., J. A. Kovacs, H. Masur, D. V. Santi, J. H. Elwood, and M. L. Sogin. 1988. Ribosomal RNA sequence shows Pneumocystis carinii to be a member of the fungi. Nature 334:519-522.
27. Edman, U., J. C. Edman, B. Lundgren, and D. V. Santi. 1989. Isolation and expression of the Pneumocystis carinii thymidylate synthase gene. Proc. Natl. Acad. Sci. USA 86:6503-6507.
28. Ezekowitz, R. A. B., D. J. Williams, H. Koziel, M. Y. K. Armstrong, A. Warner, F. F. Richards, and R. M. Rose. 1991. Uptake of Pneumocystis carinii mediated by the macrophage mannose receptor. Nature 351:155-158.
29. Fielding, A. K. 1994. Prophylaxis against late infection following splenectomy and bone marrow transplantation. Blood Rev. 8:179-191.
30. Fischl, M. A., and G. M. Dickinson. 1986. Fansidar prophylaxis of Pneumocystis pneumonia in the acquired immunodeficiency syndrome. Ann. Intern. Med. 105:629.
31. Fischl, M. A., G. M. Dickinson, and L. La Voie. 1988. Safety and efficacy of sulfamethoxazole and trimethoprim chemoprophylaxis for Pneumocystis carinii pneumonia in AIDS. JAMA 259:1185-1189.
32. Fishman, J. A. 1995. Pneumocystis carinii and parasitic infections in transplantation. Infect. Dis. Clin. N. Am. 9:1005-1044.
33. Fishman, J. A. 1993. A gene family related to the major antigen gene of Pneumocystis. In Bristol-Myers Squibb Symposium on Cell and Molecular Biology of Bacterial-Host Cell Interactions.
34. Fishman, J. A. 1995. Case records of the Massachusetts General Hospital. N. Engl. J. Med. 332:249-258.
35. Fishman, J. A., S. F. Queener, R. S. Roth, and M. S. Bartlett. 1993. Activity of topoisomerase inhibitors against Pneumocystis carinii in vitro and in an inoculated mouse model. Antimicrob. Agents Chemother. 37:1543-1546.
36. Freedberg, K., W. Hardy, R. Holzman, A. Tosteson, and D. Craven. 1996. Validating literature-based models with direct clinical trial results: the cost-effectiveness of secondary prophylaxis for PCP in AIDS patients. Med. Decision Making 16:29-35.
37. Furlong, S., K. Thibault, J. Samia, R. Rose, and J. Fishman. 1994. Lipids characteristic of fungi in Pneumocystis carinii. Antimicrob. Agents Chemother. 38:2534-2540.
38. Furuta, T., K. Ueda, K. Fujiwara, and K. Yamanouchi. 1985. Cellular and humoral immune responses of mice subclinically infected with Pneumocystis carinii. Infect. Immun. 47:544-548.
39. Gallant, J. E., S. M. McAvinue, R. D. Moore, J. G. Bartlett, D. Stanton, and R. E. Chaisson. 1995. The impact of prophylaxis on outcome and resource. Chest 107:1018-1023.
40. Gigliotti, F., and W. T. Hughes. 1988. Passive immunoprophylaxis with specific monoclonal antibody confers partial protection against Pneumocystis carinii pneumonitis in animal models. J. Clin. Invest. 81:1666-1668.
41. Gigliotti, F., and T. McCool. 1996. Glycoprotein A is the immunodominant antigen of Pneumocystis carinii in mice following immunization. Parasitol. Res. 82:90-91.
42. Girard, P., R. Landman, C. Gaudebout, R. Olivares, A. G. Saimot, P. Jelazko, A. Certain, F. Boue, E. Bouvet, T. Lecompte, J. Coulaud, and The PRIO Study Group. 1993. Dapson-pyrimethamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. N. Engl. J. Med. 328:1514-1520.
43. Hardy, A. M., C. P. Wajszczuk, A. F. Suffredini, T. R. Hakala, and M. Ho. 1984. Pneumocystis carinii pneumonia in renal transplant recipients treated with cyclosporine and steroids. J. Infect. Dis. 149:143-147.
44. Hardy, W. D. 1992. A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trials Group Protocol 021. N. Engl. J. Med. 327:1842-1848.
45. Hartsell, W. F., E. A. Czyzewski, R. Ghalie, and H. Kaizer. 1995. Pulmonary complications of bone marrow transplantation: a comparison of total body irradiation and cyclophosphamide to husulfan and cyclophosphamide. Inter. J. Radiat. Oncol. Biol. Physics 32:69-73.
46. Hennequin, C., J. Dupouy-Camet, T. Giraud, M. E. Bougnoux, J. F. Dhainaut, and C. Tourte-Schaefer. 1993. Multiple pulmonary infections in a patient with acquired immunodeficiency syndrome. Eur. J. Med. 2:250-251.
47. Hennequin, C., B. Page, P. Roux, C. Legendre, and H. Kreis. 1995. Outbreak of Pneumocystis carinii pneumonia in a renal transplant unit. Eur. J. Clin. Microbiol. Infect. Dis. 14:122-126.
48. Higgins, R. M., S. L. Bloom, J. M. Hopkin, and P. J. Morris. 1989. The risks and benefits of low-dose cotrimoxazole prophylaxis for Pneumocystis pneumonia in renal transplantation. Transplantation 47:558-560.
49. Hirschel, B., A. Lazzarin, P. Chopard, M. Opravil, H. Furrer, S. Ruttimann, P. Vernazza, J. Chave, F. Ancarani, V. Gabriel, A. Heald, R. King, R. Malinverni, J. Martin, B. Mermillod, L. Nicod, L. Simoni, M. C. Vivrito, R. Zerboni, and Swiss Group for Clinical Studies on AIDS. 1991. A controlled study of inhaled pentamidine for primary prevention of Pneumocystis carinii pneumonia. N. Engl. J. Med. 324:1079-1083.
50. Hoover, D. R., N. M. H. Graham, H. Bacellar, L. K. Schrager, R. Kaslow, B. Visscher, R. Murphy, R. Anderson, and A. Saah. 1991. Epidemiologic patterns of upper respiratory illness and Pneumocystis carinii pneumonia in homosexual men. Am. Rev. Respir. Dis. 144:756-759.
51. Hoover, D. R., A. J. Saah, H. Bacellar, J. Phair, R. Detels, R. Anderson, R. A. Kaslow, and Multicenter AIDS Cohort Study. 1993. Clinical manifestations of AIDS in the era of Pneumocystis prophylaxis. N. Engl. J. Med. 329:1922-1926.
52. Hopkin, J. M., J. H. Turney, J. A. Young, D. Adu, and J. Michael. 1983. Rapid diagnosis of obscure pneumonia in immunosuppressed renal patients by cytology of alveolar lavage fluid. Lancet ii:299-301.
53. Hughes, W., S. LaFon, J. Scott, and H. Masur. 1995. Adverse events associated with trimethoprim-sulfamethoxazole and atovaquone during the treatment of AIDS-related Pneumocystis carinii pneumonia. J. Infect. Dis. 171:1295-1301.
54. Hughes, W. T., S. Feldman, R. J. Aur, M. S. Verzosa, H. O. Hustu, and J. V. Simone. 1975. Intensity of immunosuppressive therapy and the incidence of Pneumocystis carinii pneumonitis. Cancer 36:2004-2009.
55. Hughes, W. T. 1987. Pneumocystis carinii pneumonitis. CRC Press, Inc., Boca Raton, Fla.
56. Hughes, W. T., G. Leoung, F. Kramer, S. A. Bozzette, S. Safrin, P. Frame, N. Clumeck, H. Masur, D. Lancaster, C. Chan, J. Lavelle, J. Rosenstock, J. Falloon, J. Feinberg, S. LaFon, M. Rogers, and F. Sattler. 1993. Comparison of atovaquone (566C80) and trimethoprim-sulfamethoxazole to treat Pneumocystis carinii pneumonia in patients with AIDS. N. Engl. J. Med. 328:1521-1527.
57. Hughes, W. T., S. Feldman, S. C. Chaudhary, M. Ossi, F. Cox, and S. K. Sanyal. 1978. Comparison of pentamidine isethionate and trimethoprim-sulfamethoxazole in the treatment of Pneumocystis carinii pneumonia. J. Pediatr. 92:285-291.
58. Hughes, W. T., S. Feldman, and S. K. Sanyal. 1975 Treatment of Pneumocystis carinii pneumonitis with trimethoprim/sulfamethoxazole. Can. Med. Assoc. J. 112:47S-50S.
59. Hughes, W. T., P. C. McNabb, T. D. Makres, and S. Feldman. 1974. Efficacy of trimethoprim and sulfamethoxazole in the prevention and treatment of Pneumocystis carinii pneumonitis. Antimicrob. Agents Chemother. 5:289-293.
60. Hughes, W. T., G. K. Rivera, M. J. Schell, D. Thornton, and L. Lott. 1987. Successful intermittent chemoprophylaxis for Pneumocystis carinii pneumonitis. N. Engl. J. Med. 316:1627-1632.
61. Hughes, W. T., and B. L. Smith. 1983. Intermittent chemoprophylaxis for Pneumocystis carinii pneumonia. Antimicrob. Agents Chemother. 24:300-301.
62. Hughes, W. T., and B. L. Smith. 1984. Efficacy of diaminodiphenylsulfone and other drugs in murine Pneumocystis carinii pneumonitis. Antimicrob. Agents Chemother. 26:436-440.
63. Ioannidis, J. P., J. C. Cappelleri, P. R. Skolnik, J. Lau, and H. S. Sacks. 1996. A meta-analysis of the relative efficacy and toxicity of Pneumocystis carinii pneumonia prophylactic regimens. Arch. Intern. Med. 156:177-188.
64. Ittarat, I., W. Asawamahasakda, M. S. Bartlett, J. W. Smith, and S. Meshnick. 1995. Effects of atovaquone and other inhibitors on Pneumocystis carinii dihydroorotate dehydrogenase. Antimicrob. Agents Chemother. 39: 325-328.
65. Janner, D., J. Bork, M. Baum, and R. Chinnock. 1996. Pneumocystis carinii pneumonia in infants after heart transplantation. J. Heart Lung Transplant. 15:758-763.
66. Jones, H. E., G. K. Blundell, R. R. Tidwell, J. E. Hall, S. J. Farr, and R. J. Richards. 1993. The accumulation of pentamidine and the toxic effects of the drug, its selected analogues and metabolites on isolated alveolar cells. Toxicology 80:1-12.
67. Jorde, U. P., H. W. Horowitz, and G. P. Wormser. 1993 Utility of dapsone for prophylaxis of Pneumocystis carinii pneumonia in trimethoprim-sulfamethoxazole-intolerant, HIV-infected individuals. AIDS 7:355-359.
68. Kandil, O., J. A. Fishman, H. Koziel, P. Pinkston, R. M. Rose, and H. G. Remold. 1994. Human immunodeficiency virus type I infection of human macrophages modulates the cytokine response to Pneumocystis carinii. Infect. Immun. 62:644-650.
69. Kay, R., and R. E. DuBois. 1990. Clindamycin/primaquine therapy and secondary prophylaxis against Pneumocystis carinii pneumoniain patients with AIDS. South. Med. J. 83:403-404.
70. Kovacs, J., and H. Masur. 1992. Prophylaxis for Pneumocystis carinii pneumonia in patients infected with human immunodeficiency virus. Clin. Infect. Dis. 14:1005-1009.
71. Kovacs, J. A., J. W. Hiemenz, A. M. Macher, D. Stover, H. Murray, J. Shelhamer, H. C. Lane, C. Urmacher, C. Honig, D. L. Longo, M. M. Parker, C. Natanson, J. E. Parrillo, A. S. Fauci, P. A. Pizzo, and H. Masur. 1984. Pneumocystis carinii pneumonia: a comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies. Ann. Intern. Med. 100:663-671.
72. Kovacs, J. A., F. Powell, J. C. Edman, B. Lundgren, A. Martinez, B. Drew, and C. W. Angus. 1993. Multiple genes encode the major surface glycoprotein of Pneumocystis carinii. J. Biol. Chem. 268:6034-6040.
73. Kuller, J., M. R. First, R. D'Archiardi, and R. Munda. 1982. Pneumocystis carinii pneumonia in renal transplant recipients. Am. J. Nephrol. 2:312-315.
74. Lake, K. 1995. Drug interactions in transplant patients, p. 173-200. Handbook of cardiac transplantation. Handley & Belfus, Philadelphia, Pa.
75. Lane, B. R., J. C. Ast, P. A. Hossler, D. P. Mindell, M. S. Bartlett, J. W. Smith, and S. R. Meshnick. 1997. Dihydropteroate synthase polymorphisms in Pneumocystis. J. Infect. Dis. 175:482-485.
76. LaTouche, S., J. L. Poirot, C. Bernard, and P. Roux. 1997. Study of internal transcribed spacer and mitochondrial large-subunit genes of Pneumocystis carinii hominis isolated from repeated bronchoalveolar lavage from human immunodeficiency virus-infected patients during one or several episodes of pneumonia. J. Clin. Microbiol. 35:1687-1690.
77. Lau, W. K., and L. S. Young. 1976. Trimethoprim-sulfamethoxazole treatment of Pneumocystis carinii pneumonia in adults. N. Engl. J. Med. 295: 716-718.
78. Levine, S. J., H. Masur, V. J. Gill, I. Feuerstein, A. F. Suffredini, D. Brown, H. C. Lane, R. Yarchoan, J. H. Shelhamer, and F. P. Ognibene. 1991. Effect of aerosolized pentamidine prophylaxis on the diagnosis of Pneumocystis carinii pneumonia by induced sputum examination in patients infected with the human immunodeficiency virus. Am. Rev. Respir. Dis. 144:760-764.
79. Lu, J., M. S. Bartlett, M. Shaw, S. Queener, J. W. Smith, M. Ortiz-Rivera, M. Leibowitz, and C. H. Lee. 1994. Typing of Pneumocystis carinii strains that infect humans based on nucleotide sequence variations of internal transcribed spacers of rRNA genes. J. Clin. Microbiol. 32:2904-2912.
80. Lufft, V., V. Kliem, M. Behrend, R. Pichlmayr, K. M. Koch, and R. Brunkhorst. 1996. Incidence of Pneumocystis carinii pneumonia after renal transplantation. Transplantation 63:421-423.
81. Masur, H., F. P. Ognibene, R. Yarchoan, J. H. Shelhamer, B. F. Baird, W. Travis, A. F. Suffredini, L. Deyton, J. A. Kovacs, J. Falloon, R. Davey, M. Polis, J. Metcalf, M. Baseler, R. Wesley, V. J. Gill, A. S. Fauci, and H. C. Lane. 1989. CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infection. Ann. Intern. Med. 111:223-231.
82. Mei, H. Y., M. Cui, S. M. Lemrow, and A. W. Czarnik. 1997. Discovery of selective, small molecule inhibitors of RNA complexes. II. Self-splicing group I intron ribozyme. Bioorg. Med. Chem. 5:1185-1195.
83. Meuwissen, J. H. E. T., I. Tauber, A. D. E. M. Leeuwenberg, P. J. A. Beckers, and M. Seiben. 1977. Parasitologic and serologic observations of infection with Pneumocystis in humans. J. Infect. Dis. 136:43-49.
84. Miller, R. F., J. Le Noury, E. L. Corbett, J. M. Felton, and K. M. De Cock. 1987. Pneumocystis carinii infection: current treatment and prevention. J. Antimicrob. Chemother. 37(Suppl. B):35-53.
85. Mills, J., G. Leoung, I. Medina, W. Hughes, P. Hopewll, and C. Wofsy. 1986. Dapsone is ineffective therapy for Pneumocystis pneumonia in patients with AIDS. Clin. Res. 34:101A.
86. Mirovsky, P., and J. A. Fishman. 1993. An improved method for the long term maintenance of Pneumocystis carinii in vitro. J. Infect. Dis. 167:1470-1473.
87. Mohle-Boetani, J., S. Akula, M. Holodniy, D. Katzenstein, and G. Garcia. 1992. The sulfone syndrome in a patient receiving dapsone prophylaxis for Pneumocystis carinii pneumonia. West. J. Med. 156:303-306.
88. Montgomery, A. B., D. W. Feigal, F. Sattler, G. R. Mason, A. Catanzano, R. Edison, N. Markowitz, E. Johnson, S. Ozowa, and M. Rouzar. 1995. Pentamidine aerosol versus trimethoprini-sulfamethoxazole for Pneumocystis carinii in acquired immunodeficiency syndrome. Am. J. Respir. Crit. Care 151:1068-1074.
89. Morris, S. A., R. E. Schwartz, D. F. Sesin, P. Masurekar, T. C. Hallada, D. M. Schmatz, K. Bartial, O. D. Hensens, and D. L. Zink. 1994. Pneumocandin DO, a new antifungal agent and potent inhibitor of Pneumocystis carinii. J. Antibiot. 47:755-764.
90. Mundy, L. M., P. G. Auwaerter, D. Oldach, M. L. Warner, A. Burton, E. Vance, C. A. Gaydos, J. M. Joseph, R. Gopalan, and R. D. Moore. 1995. Community-acquired pneumonia: impact of immune status. Am. J. Respir. Crit. Care Med. 152:1309-1315.
91. Murray, H. W., R. A. Gellene, and D. M. Libby. 1985. Activation of tissue macrophages from AIDS patients: in vitro response of AIDS alveolar macrophages to lymphokines and interferon-gamma. J. Immunol. 135:2374-2377.
92. Nathan, S. D., D. J. Ross, P. Zakowski, R. M. Kass, and S. K. Koerner. 1994. Utility of inhaled pentamidine prophylaxis in lung transplant reciepients. Chest 105:417-420.
93. Nicod, L. P. 1996. Infectious complications of lung and heart-lung transplantation. Rev. Mal. Respir. 13(5 Suppl.):S41-S47.
94. Nottet, H. S. L. M., L. de Graaf, N. M. de Vos, L. J. Bakker, J. A. G. van Strijp, M. R. Visser, and J. Verhoef. 1993. Phagocytic function of monocyte-derived macrophages is not affected by human immunodeficiency virus type 1 infection. J. Infect. Dis. 168:84-91.
95. Olsen, S. L., D. G. Renlund, J. B. O'Connell, D. O. Taylor, J. E. Lassetter, and J. Eastburn. 1993. Prevention of Pneumocystis carinii in cardiac transplantation recipients by trimethoprim-sulfamethoxazole. Transplantation 56:359-362.
96. Opravil, M., B. Joos, and R. Luthy. 1994. Levels of dapsone and pyrimethamine in serum during once-weekly dosing for prophylaxis against Pneumocystis carinii pneumonia and toxoplasmic encephalitis. Antimicrob. Agents Chemother. 38:1197-1199.
97. Opravil, M., B. Joos, and R. Luthy. 1993. Dapsone-pyrimethamine vs. aerosolized pentamidine for combined prophylaxis of PCP and toxoplasmic encephalitis, abstr. PO-B10-1429. In Abstracts of the IX International Conference on AIDS.
98. Opravil, M., G. Keusch, and R. L'Uthy. 1993. Pyrimethamine inhibits renal secretion of creatinine. Antimicrob. Agents Chemother. 37:1056-1060.
99. Oz, H. S., and W. T. Hughes. 1997. Novel anti-Pneumocystis carinii effects of the immunosuppressant mycophenolate mofetil in contrast to provocative effects of tacrolimus. J. Infect. Dis. 175:901-904.
100. Perera, D. R., K. A. Western, H. D. Johnson, W. W. Johnson, M. G. Schultz, and P. V. Akers. 1970. Pneumocystis carinii pneumonia in a hospital for children: epidemiologic aspects. JAMA 214:1074-1078.
101. Phair, J., H. Masur, P. Gross, K. Holmes, and J. Kaplan. 1995. Quality standard for the prophylaxis of Pneumocystis carinii pneumonia in adults and adolescents infected with human immunodeficiency virus. Clin. Infect. Dis. 21(Suppl. 1):S128-S129.
102. Pifer, L. L., W. T. Hughes, and M. J. Murphy. 1977. Propagation of Pneumocystis carinii in vitro. Pediatr. Res. 11:305-316.
103. Plettenberg, A., U. van Dyk, A. Stoehr, H. Albrecht, H. J. Stellbrink, J. Berger, and W. Meigel. 1997. Increased risk for opportunistic infections during chemotherapy in HIV-infected patients with Kaposi's sarcoma. Dermatology 194:234-237.
104. Podzamczer, D., M. Santin, J. Jimenez, A. Casanova, F. Bolao, and G. R. Gudiol. 1993. Thrice-weekly cotrimoxazole is better than weekly dapsonepyrimethamine for the primary prevention of Pneumocystis carinii pneumonia in HIV-infected patients. AIDS 7:501-506.
105. Podzamczer, D., A. Salazar, J. Jiminez, E. Consiglio, M. Santrin, A. Casanova, G. Rufi, and F. Gudiol. 1995. Intermittent trimethoprim-sulfamethoxazole compared with dapsone-pyrimethamine for the simultaneous primary prophylaxis of Pneumocystis pneumonia and toxoplasmosis in patients infected with HIV. Ann. Intern. Med. 122:755-761.
106. Post, C., T. Fakoughi, W. Dutz, B. Bandarizadeh, and E. E. Kohout. 1971. Prophylaxis of epidemic infantile pneumocystosis with a 20:1 sulfadoxine and pyrimethamine combination. Curr. Ther. Res. 13:273-279.
107. Principi, N., P. Marchisio, J. Onorato, C. Gabiano, L. Galli, D. Caselli, B. Morandi, A. Campelli, M. Clerici, and G. C. Gattinora. 1996. Long-term administration of aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia in infants and children with symptomatic HIV infection. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 12:158-163.
108. Rizzardi, G., A. Lazzarin, M. Musicco, D. Frigerio, M. Maillard, M. Lucchini, and M. Moroni. 1996. Risks and benefits of aerosolized pentamidine and cotrimoxazolee in primary prophylaxis of Pneumocystis carinii pneumonia in HIV-1-infected patients: a two-year Italian multicentric randomized controlled trial. The Italian PCP Study Group. J. Infect. 32:123-131.
109. Rizzardi, G. P., A. Lazzarin, M. Musicco, D. Frigerio, M. Maillard, M. Lucchini, and M. Moroni. 1995. Better efficacy of twice-monthly than monthly aerosolised pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with AIDS. J. Infect. Dis. 31:99-105.
110. Robbins, J. B., V. T. DeVita, and W. Dutz (ed.) 1976. Symposium on Pneumocystis carinii infection. NCI Monograph No. 43. National Cancer Institute, Washington, D.C.
111. Roudier, C., E. Caumes, O. Rogeaux, F. Bricaire, and M. Gentilini. 1994. Adverse cutaneous reactions to trimethoprim-sulfamethoxazole in patients with acquired immunodeficiency syndrome and Pneumocystis carinii pneumonia. Arch. Dermatol. 130:1383-1386.
112. Ruebush, T. K., R. A. Weinstein, R. L. Baehner, D. Wolff, M. S. Bartlett, F. Gonzales-Crussi, A. J. Sulzer, and M. G. Schultz. 1978. An outbreak of Pneumocystis pneumonia in children with acute lymphocytic leukemia. J. Dis. Child. 132:143-148.
113. Ruiz Ruiz, J., M. Yebra Bango, J. Fernandez Fernandez, and L. Alonso Pulpon. 1997. Pneumocystis carinii pneumonia in patients with solid organ transplants: a report of 5 cases. Rev. Clin. Esp. 197:31-34.
114. Ruskin, J., and M. LaRiviere. 1991. Low dose co-trimoxazole for prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus disease. Lancet 337:468-471.
115. Saah, A., D. R. Hoover, Y. Peng, J. P. Phair, B. Visscher, L. A. Kingsley, and L. K. Schrager. 1995. Predictors of failure of Pneumocystis carinii pneumonia prophylaxis. JAMA 273:1197-1202.
116. Safrin, S., B. Lee, and M. Sande. 1994. Adjunctive folinic acid with trimethoprim-sulfamethoxazole for Pneumocystis carinii pneumonia in AIDS patients is associated with an increased risk of therapeutic failure and death. J. Infect. Dis. 170:912-917.
117. Salmon Ceron, D., A. Fontbonne, J. Saba, T. May, F. Raffi, C. Chidiac, and G. Patey. 1995. Lower survival in AIDS patients receiving dapsone compared with aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia. J. Infect. Dis. 172:656-664.
118. Sands, F., M. Kron, and R. Brown. 1985. Pentamidine: a review. Rev. Infect. Dis. 7:625-634.
119. Saukkonen, K., R. Garland, and H. Koziel. 1996. Aerosolized pentamidine as alternative primary prophylaxis against Pneumocystis carinii pneumonia in adult hepatic and renal transplant recipients. Chest 109:1250-1255.
120. Schneider, M., M. E. Margriet, A. Hoepelman, J. Karrel, J. Eeftinck-Schattenkerk, T. L. Nielsen, Y. van der Graaf, J. Frissen, I. M. E. van der Ende, A. F. P. Kolsters, J. C. C. Borleffs, and the Dutch AIDS Treatment Group. 1992. A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. N. Engl. J. Med. 327:1836-1841.
121. Shearer, C., and P. H. Chandrasekar. 1995. Pulmonary nocardiosis in a patient with a bone marrow transplant. Bone Marrow Transplant. 15:479-481.
122. Sierra-Madero, J. G., Z. Toossi, D. L. Hom, C. K. Finegan, E. Hoenig, and E. A. Rich. 1994. Relationship between load of virus in alveolar macrophages from human immunodeficiency virus type 1-infected persons, production of cytokines, and clinical status. J. Infect. Dis. 169:18-27.
123. Simonds, R., W. Hughes, J. Feinberg, and T. Navin. 1995. Preventing Pneumocystis carinii pneumonia in persons infected with human immunodeficiency virus. Clin. Infect. Dis. 21(Suppl. 1):S44-S48.
124. Simonds, R. J., M. L. Lindegren, P. Thomas, D. Hanson, B. Caldwell, G. Scott, and M. Rogers. 1995. Prophylaxis against Pneumocystis carinii pneumonia among children with perinataliy acquired human immunodeficiency virus infection in the United States. N. Engl. J. Med. 332:786-790.
125. Sin, D., and S. Shafran. 1996. Dapsone- and primaquine-induced methemoglobinemia in HIV-infected individuals. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 15:477-481.
126. Singh, N., T. Gayowski, M. Wagener, I. R. Marino, and V. L. Yu. 1996. Pulmonary infections in liver transplant recipients receiving tacrolimus. Transplantation 61:396-401.
127. Slavin, M. 1992. Oral dapsone versus nebulized pentamidine for Pneumocystis carinii pneumonia prophylaxis: an open randomized prospective trial to assess efficacy and hematological toxicity. AIDS 6:1169-1174.
128. Slivka, A., P. Y. Wen, W. M. Shea, and J. S. Loeffler. 1993. Pneumocystis carinii pneumonia during steroid taper in patients with primary brain tumors. Am. J. Med. 94:216-219.
129. Stringer, J. 1996. Pneumocystis carinii: what is it, exactly? Clin. Microbiol. Rev. 9:489-498.
130. Swartzberg, J. E., and J. S. Remington. 1979. Transplant associated infections, p. 453-488. In J. V. Bennett and P. S. Brachman (ed.), Hospital infections. Little, Brown & Co., Boston, Mass.
131. Thea, D. M., G. Lambert, J. Weedon, P. B. Matheson, E. J. Abrams, M. Bamji, and T. Straus. 1996. Benefit of primary prophylaxis before 18 months of age in reducing the incidence of Pneumocystis carinii pneumonia and early death in a cohort of 112 human immunodeficiency virus-infected infants. Pediatrics 97:59-64.
132. Torre Cisneros, J., M. de la Mata, P. Lopez Cillero, P. Sanchez Guijo, and P. Mino. 1996. Effectiveness of daily low-dose cotrimoxazole prophylaxis for Pneumocystis carinii pneumonia in liver transplantation - an open clinical trial. Transplantation 62:1519-1521.
133. van Dissel, J. T., J. M. Zijlmans, A. C. Kroes, and W. E. Fibbe. 1995. Respiratory syncytial virus, a rare cause of severe pneumonia following bone marrow transplantation. Ann. Hematol. 71:253-255.
134. Vanek, J., and O. Jirovec. 1952. Parasitare penumonie: "interstitielle" plasmazell pneumonie der frugeburten verursach durch Pneumocystis carinii. Zentralbl. Bakteriol. Parasitenkd. Infektionskr. Hyg. Abt. 1 Orig. 158: 120-127.
135. Voeller, D., J. Kovacs, V. Andrawis, E. Chu, H. Masur, and C. Allegra. 1994. Interaction of Pneumocystis carinii dihydropteroate synthase with sulfonamides and diaminodiphenyl sulfone (dapsone). J. Infect. Dis. 169:456-459.
136. Vogel, P., C. J. Miller, L. L. Lowenstine, and A. A. Lackner. 1993. Evidence of horizontal transmission of Pneumocystis carinii pneumonia in simian immunodeficiency virus-infected rhesus macaques. J. Infect. Dis. 168:836-843.
137. Wada, M., K. Katada, M. Saito, K. Egawa, and Y. Nakamura. 1993. cDNA sequence diversity and genomic clusters of major surface glycoprotein genes of Pneumocystis carinii. J. Infect. Dis. 168:979-985.
138. Wall, P. G., K. Porter, A. Noone, and D. J. Goldberg. 1993. Changing incidence of Pneumocystis carinii pneumonia as the initial AIDS-defining disease in the United Kingdom. AIDS 7:1523-1525.
139. Walzer, P. D. 1994. Pneumocystis carinii pneumonia. Marcel Dekker, Inc., New York, N.Y.
140. Walzer, P. D., D. P. Perl, D. J. Krogstad, P. G. Rawson, and M. G. Schultz. 1974. Pneumocystis carinii pneumonia in the United States: epidemiologic, diagnostic, and clinical features. Ann. Intern. Med. 80:83-93.
141. Watanabe, J., H. Hori, K. Tanabe, and Y. Nakamura. 1989. Phylogenetic association of Pneumocystis carinii with the 'rhizopoda/myxomycota/zygomycota group' indicated by comparison of 5S ribosomal RNA sequences. Mol. Biochem. Parasitol. 32:163-168.
142. Winston, D. J., W. K. Lau, R. P. Gale, and L. S. Young. 1980. Trimethoprim-sulfamethoxazole for the treatment of Pneumocystis carinii pneumonia. Ann. Intern. Med. 92:762-769.
143. Young, R. C., and V. T. DeVita. 1976. Treatment of Pneumocystis carinii pneumonia, p. 193-198. In J. B. Robbins, V. T. DeVita, and W. Dutz (ed.), Symposium on Pneumocystis carinii infection. NCI Monograph No. 43. National Cancer Institute, Washington, D.C.
144. Ypma-Wong, M. F., W. A. Fonzi, and P. S. Sypherd. 1992. Fungus-specific translation elongation factor 3 gene present in Pneumocystis carinii. Infect. Immun. 60:4140-4145.